Lumos Pharma, Inc. (LUMO)
NASDAQ: LUMO · IEX Real-Time Price · USD
1.510
+0.050 (3.42%)
Jul 22, 2024, 9:54 AM EDT - Market open
Lumos Pharma Employees
Lumos Pharma had 33 employees as of December 31, 2023. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
$46,212
Profits / Employee
-$1,125,121
Market Cap
12.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 33 | 1 | 3.13% |
| Dec 31, 2022 | 32 | 0 | - |
| Dec 31, 2021 | 32 | 3 | 10.34% |
| Dec 31, 2020 | 29 | 8 | 38.10% |
| Dec 31, 2019 | 21 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Integrated Sciences | 230 |
| Ontrak | 104 |
| Check-Cap | 85 |
| RedHill Biopharma | 53 |
| Calidi Biotherapeutics | 41 |
| Aptose Biosciences | 36 |
| Imunon | 33 |
| Monopar Therapeutics | 10 |
LUMO News
- 2 months ago - Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024 - GlobeNewsWire
- 2 months ago - Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024 - GlobeNewsWire
- 3 months ago - Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings - GlobeNewsWire
- 4 months ago - Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 - GlobeNewsWire
- 4 months ago - Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update - GlobeNewsWire
- 5 months ago - Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024 - GlobeNewsWire
- 5 months ago - Lumos Pharma to Participate in Oppenheimer's 34th Annual Healthcare Life Sciences Conference - GlobeNewsWire